Compare AU
Compare IOO vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global 100 Large-Caps (IOO) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IOO | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 882 | 63 |
Median incremental investment | $1,002.61 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,523.30 | $1,875.72 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
IOO | DRUG | |
|---|---|---|
Strategy | The iShares Global 100 ETF seeks to track the performance of the S&P Global 100 Index. It consists of 100 large-cap global equities. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Microsoft Corporation (12.34 %) Apple, Inc. (10.21 %) NVIDIA Corporation (9.04 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (99.97 %) Communication Services (0.03 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | United States (99.99 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.4 % | 0.57 % |
Key Summary
IOO | DRUG | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | S&P Global 100 Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.4 % | 0.57 % |
Price | $160.15 | $8.12 |
Size | $4.364 billion | $191.120 million |
10Y return | 247.28 % | N/A |
Annual distribution yield (5Y) | 1.61 % | 1.90 % |
Market | ASX | ASX |
First listed date | 10/10/2007 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IOO | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 882 | 63 |
Median incremental investment | $1,002.61 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,523.30 | $1,875.72 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
IOO | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IOO | DRUG |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |